Scott K. Tyldesley
600 W 10th Ave
Vancouver, BC, Canada
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 125 publications
NeoBLAST: A Pilot Randomized Controlled Trial of Active Surveillance Versus Definitive Bladder Treatment Following Clinical Complete Response to Neoadjuvant Therapy in Muscle-invasive Bladder Cancer - Study Protocol.
Journal: European urology oncology
Published: March 23, 2026
Five-year follow-up of the SABR-5 trial: primary toxicity analysis of stereotactic ablative radiotherapy for up to five oligometastases.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: February 21, 2026
Treatment With Stereotactic Ablative Radiation Therapy for Patients With up to 5 Oligometastatic Cancer Lesions: Long-Term Outcomes of the Nonrandomized Population-based Phase 2 SABR-5 Clinical Trial.
Journal: International journal of radiation oncology, biology, physics
Published: October 24, 2025
Multinational validation of distant metastasis velocity as a post-progression prognostic score in patients with oligometastatic cancer treated with metastasis-directed stereotactic body radiotherapy.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 18, 2025
Development of Radiomics Models to Predict Progression-Free Survival and Early Polymetastatic Progression in Patients With Lung Oligometastases Treated on the Single-Arm Phase II Stereotactic Ablative Radiotherapy-5 Trial.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: May 10, 2025
Metastases-directed therapy in addition to standard systemic therapy in oligometastatic castration-resistant prostate cancer in Canada (GROUQ-PCS 9): a multicentre, open-label, randomised, phase 2 trial.
Journal: The Lancet. Oncology
Published: March 31, 2025
Impact of clinical target volume utilization on outcomes in patients with non-spine bone oligometastases treated with stereotactic ablative radiation therapy.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: January 27, 2025
The Impact of Ultracentral Tumor Location on Outcomes in Patients with Pulmonary Oligometastases: A Secondary Analysis of the Single-Arm Phase 2 SABR-5 Trial.
Journal: International journal of radiation oncology, biology, physics
Published: November 18, 2024
Evaluating Toxicity and Interaction Outcomes of Systemic Therapy and Stereotactic Ablative Radiation Therapy for Oligometastatic Disease: A Secondary Analysis of the Phase 2 SABR-5 Trial.
Journal: International journal of radiation oncology, biology, physics
Published: October 16, 2024
Real-world evaluation of access-driven Canadian treatment sequences in progressive prostate cancer (REACTIVATE).
Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: July 29, 2024
Prognostic significance of a negative PSMA PET/CT in biochemical recurrence of prostate cancer.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: May 15, 2024
Last Updated: 09/26/2026